COMMERCIAL BANCGROUP INC (CBK) Stock Fundamental Analysis

NASDAQ:CBK • US20112C1062

25.89 USD
-0.13 (-0.5%)
At close: Feb 13, 2026
25.89 USD
0 (0%)
After Hours: 2/13/2026, 8:00:02 PM
Fundamental Rating

2

Overall CBK gets a fundamental rating of 2 out of 10. We evaluated CBK against 381 industry peers in the Banks industry. CBK has a bad profitability rating. Also its financial health evaluation is rather negative. CBK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CBK was profitable.
CBK Yearly Net Income VS EBIT VS OCF VS FCFCBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 10M 20M 30M

1.2 Ratios

  • CBK has a better Return On Assets (2.64%) than 99.48% of its industry peers.
  • With an excellent Return On Equity value of 23.85%, CBK belongs to the best of the industry, outperforming 99.21% of the companies in the same industry.
Industry RankSector Rank
ROA 2.64%
ROE 23.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBK Yearly ROA, ROE, ROICCBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of CBK (37.63%) is better than 93.18% of its industry peers.
  • CBK does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 37.63%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBK Yearly Profit, Operating, Gross MarginsCBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

  • CBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CBK has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for CBK has been reduced compared to a year ago.
CBK Yearly Shares OutstandingCBK Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2M 4M 6M 8M 10M
CBK Yearly Total Debt VS Total AssetsCBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • A Debt/Equity ratio of 0.66 indicates that CBK is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.66, CBK is not doing good in the industry: 79.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.41%
CBK Yearly LT Debt VS Equity VS FCFCBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBK Yearly Current Assets VS Current LiabilitesCBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2M 4M 6M 8M

1

3. Growth

3.1 Past

  • CBK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.33%.
  • Looking at the last year, CBK shows a quite strong growth in Revenue. The Revenue has grown by 8.25% in the last year.
EPS 1Y (TTM)2.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)8.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBK Yearly Revenue VS EstimatesCBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 20M 40M 60M 80M

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 5.95, the valuation of CBK can be described as very cheap.
  • 96.33% of the companies in the same industry are more expensive than CBK, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of CBK to the average of the S&P500 Index (27.19), we can say CBK is valued rather cheaply.
Industry RankSector Rank
PE 5.95
Fwd PE N/A
CBK Price Earnings VS Forward Price EarningsCBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBK Per share dataCBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

  • CBK has a Yearly Dividend Yield of 1.54%.
  • CBK's Dividend Yield is slightly below the industry average, which is at 2.78.
  • CBK's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

  • CBK is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
CBK Yearly Dividends per shareCBK Yearly Dividends per shareYearly Dividends per share 2026 0.02 0.04 0.06 0.08

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
CBK Yearly Income VS Free CF VS DividendCBK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2023 2024 10M 20M 30M

COMMERCIAL BANCGROUP INC

NASDAQ:CBK (2/13/2026, 8:00:02 PM)

After market: 25.89 0 (0%)

25.89

-0.13 (-0.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-26
Earnings (Next)N/A
Inst Owners11.16%
Inst Owner Change247750%
Ins Owners13.87%
Ins Owner Change-90.17%
Market Cap354.69M
Revenue(TTM)155.37M
Net Income(TTM)58.47M
Analysts80
Price Target31.62 (22.13%)
Short Float %3.23%
Short Ratio3.16
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date03-13
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.12%
PT rev (3m)-3.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.95
Fwd PE N/A
P/S 2.28
P/FCF N/A
P/OCF N/A
P/B 1.45
P/tB 1.53
EV/EBITDA N/A
EPS(TTM)4.35
EY16.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.34
BVpS17.89
TBVpS16.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number41.85
Profitability
Industry RankSector Rank
ROA 2.64%
ROE 23.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 37.63%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC7.41%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.54%
OCF growth 3YN/A
OCF growth 5YN/A

COMMERCIAL BANCGROUP INC / CBK FAQ

What is the ChartMill fundamental rating of COMMERCIAL BANCGROUP INC (CBK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CBK.


What is the valuation status for CBK stock?

ChartMill assigns a valuation rating of 2 / 10 to COMMERCIAL BANCGROUP INC (CBK). This can be considered as Overvalued.


How profitable is COMMERCIAL BANCGROUP INC (CBK) stock?

COMMERCIAL BANCGROUP INC (CBK) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CBK stock?

The Price/Earnings (PE) ratio for COMMERCIAL BANCGROUP INC (CBK) is 5.95 and the Price/Book (PB) ratio is 1.45.